Related Experiment Video
Updated: Jun 29, 2025

How to Administer Near-Infrared Spectroscopy in Critically ill Neonates, Infants, and Children
Published on: August 19, 2020
Neurologic Statistical Prognostication and Risk Assessment for Kids on Extracorporeal Membrane Oxygenation-Neuro
Neel Shah1, Saurabh Mathur2, Prashanth Shanmugham3
1From the Department of Pediatrics, Washington University in St. Louis, St. Louis, Missouri.
Neuro-SPARK is the first scoring system to predict neurologic injury in pediatric and neonatal patients on extracorporeal membrane oxygenation (ECMO). This tool aids clinicians in risk assessment and targeted neuromonitoring for improved outcomes.
Area of Science:
- Pediatric critical care medicine
- Neurology
- Biomedical engineering
Background:
- Neurologic injury is a significant complication in pediatric and neonatal patients undergoing extracorporeal membrane oxygenation (ECMO).
- Existing risk assessment tools for ECMO-associated neurologic injury are limited.
- Understanding specific risk factors for different ECMO configurations (veno-venous vs. veno-arterial) is crucial.
Purpose of the Study:
- To develop and validate Neuro-SPARK, a novel scoring system for assessing neurologic injury risk in pediatric and neonatal ECMO patients.
- To create separate predictive models for veno-venous (V-V ECMO) and veno-arterial (V-A ECMO) configurations.
- To identify key predictors of neurologic injury in these patient populations.
Main Methods:
- Utilized a 10-year dataset from the Extracorporeal Life Support Organization (ELSO) registry.
- Applied robust machine learning methodologies and clinical expertise.
- Developed distinct models for V-V ECMO and V-A ECMO, identifying 14 and 20 predictor variables, respectively.
Main Results:
- The Neuro-SPARK models demonstrated moderate accuracy in predicting neurologic injury (AUROC for V-V ECMO = 0.63, V-A ECMO = 0.64).
- Models exhibited good calibration, as indicated by Brier scores (V-V ECMO = 0.1, V-A ECMO = 0.15).
- Post-hoc analysis identified distinct high- and low-risk patient groups.
Conclusions:
- Neuro-SPARK represents the first risk-assessment tool for neurologic injury in pediatric and neonatal ECMO patients.
- The system can aid clinicians in targeted neuromonitoring and guide future research.
- This tool has the potential to improve patient outcomes by enabling proactive risk management.
More Related Videos
03:40Point-of-Care Ultrasound for Peripheral Veno-Arterial Extracorporeal Membrane Oxygenation Without Left Ventricular Venting
Published on: January 17, 2025
05:52Early Pathological and Magnetic Resonance Detection of Cerebral Injury Using a Rat Model of Neonatal Hypoxic Ischemic Encephalopathy
Published on: October 28, 2022